EU Cosmetics Compliance for Private Label Hair Care

FORMULATOR-TO-MARKET GUIDE | EU COSMETICS COMPLIANCE

EU Cosmetics Compliance for Private Label Hair Care: A Formulator-to-Market Guide

2026 EU Market-Entry Guide for Hair Care Brands

Launching a private label shampoo, conditioner, hair mask, styling product or cosmetic scalp serum in the European Union requires more than a good formula and a supplier’s certificate package. The finished product needs a defined cosmetic classification, an EU Responsible Person, a compliant formula, a Cosmetic Product Safety Report, a Product Information File, good manufacturing practice, compliant labeling and claims, and CPNP notification before market placement. These activities must apply to the exact commercial formula and package—not merely to a laboratory sample or a similar stock product. This guide shows brand owners how to build those requirements into an OEM project from the first brief.

EU Cosmetics Compliance for Private Label Hair Care: A Formulator-to-Market Guide

Does the Product Fall Within the EU Cosmetic Definition?

Classification comes before formulation and claims. Regulation (EC) No 1223/2009 defines a cosmetic product by where it is used and its exclusive or main purpose, including cleaning, perfuming, changing appearance, protecting or keeping external body parts—including the hair system—in good condition.

Many familiar products can fit the cosmetic framework:

Shampoo and dry shampoo
Conditioner and hair mask
Hair oil and cosmetic scalp serum
Hair fiber and root-concealer powder
Styling powder, wax, clay, gel and hair spray
Hair perfume and sea salt spray
Hair dye and color products, subject to detailed ingredient restrictions and warnings

A cosmetic cannot be converted into a treatment simply by changing marketing language. Claims about treating alopecia, regrowing hair, altering physiological functions or addressing disease can move a product outside the cosmetic boundary. Minoxidil products, for example, should not be placed into an EU cosmetic project merely because they are presented in a serum bottle.

Define intended use in writing

The project brief should state application site, rinse-off or leave-on status, spray or non-spray use, target population, frequency, exposure and proposed claims. These facts affect ingredient restrictions and the safety assessment. A scalp spray and a rinse-off shampoo containing the same ingredient are not automatically assessed in the same way.

Who Is Responsible: Brand, Manufacturer, Importer or EU Responsible Person?

EU compliance is a chain of assigned responsibilities. A private label manufacturer can provide formula and production information, but it does not automatically become the EU Responsible Person.

Brand owner

The brand normally defines the target market, product concept, claims, artwork and commercial distribution. It should contractually establish who owns the formula and testing, who maintains documents, who approves changes and who handles regulatory updates.

Non-EU manufacturer

The manufacturer produces the product to an approved specification and supplies the documents and samples agreed for safety assessment, PIF preparation and market-entry work. Its exact obligations depend on the supply agreement and applicable law.

Importer

For an imported cosmetic product, the importer is generally the Responsible Person for the specific product it places on the market unless another person established in the EU has been designated in writing and accepts that role in writing, in accordance with the Regulation.

EU Responsible Person

Only cosmetic products for which a legal or natural person within the EU is designated as Responsible Person may be placed on the market. The RP is not simply a mailbox address. The role is connected to safety assessment, PIF availability, notification, labeling, claims, corrective action, authority cooperation and other compliance duties.

Distributor

Distributors also have due-care obligations. In certain circumstances—such as placing a cosmetic under their own name or trademark or modifying a product in a way that may affect compliance—their role can change. Translation of label information has its own notification and accuracy considerations.

Allocate these roles before packaging artwork is finalized. Printing an EU address does not by itself create a valid Responsible Person arrangement.

What Is the Correct EU Compliance Workflow for Private Label Hair Care?

The most efficient approach is to treat compliance as a sequence of approval gates. Completing CPNP at the end cannot repair a restricted ingredient, inadequate safety file or non-compliant claim.

Classify the product: Confirm that the intended purpose and claims fit the cosmetic definition.
Appoint the Responsible Person: Agree the role, territory, fees, document access and change-notification process.
Freeze the formula identity: Assign a code and version to the exact qualitative and quantitative formula.
Screen ingredients: Check prohibitions, restrictions, permitted colorants, preservatives and UV filters, impurities, nanomaterials and use conditions against current rules.
Plan testing and evidence: Establish stability, compatibility, microbiological and claim-substantiation needs based on product type.
Complete the CPSR: Provide the qualified safety assessor with the data needed for Parts A and B.
Compile the PIF: Connect product description, CPSR, manufacturing method/GMP statement, claim evidence and animal-testing data required by the Regulation.
Approve compliant artwork: Verify mandatory particulars, INCI list, language, precautions and Responsible Person details.
Notify through CPNP: The Responsible Person submits the required product information before market placement.
Release and monitor: Produce the approved version, maintain traceability, handle undesirable effects and update compliance when anything changes.

How Should a Hair Care Formula Be Screened for EU Compliance?

A formula review should use the current consolidated Cosmetics Regulation and its annexes. The Regulation continues to be amended; a formula cleared several years ago should not be assumed compliant in 2026.

Check every ingredient and function

The assessment should cover the exact INCI identity, concentration, function, supplier specification and foreseeable impurities. The annex system includes:

Annex II: prohibited substances
Annex III: restricted substances and conditions of use
Annex IV: allowed colorants
Annex V: allowed preservatives
Annex VI: allowed UV filters

CosIng can be a helpful European Commission ingredient-information database, but a database entry is not, by itself, proof that every use and concentration is legally permitted. The legal annexes and current amendments control.

Rinse-off, leave-on and spray exposure matter

Restrictions can differ by product type, site, age group and exposure route. This is especially relevant to hair sprays, aerosol products, scalp serums, dyes and products used near the eyes. The assessor needs the real use scenario, not merely the marketing category “hair care.”

Natural and essential oils still require review

“Natural,” “organic” or botanical origin does not exempt an ingredient from restrictions, allergens, impurities, oxidation concerns or safety assessment. Rosemary, fragrance and essential-oil concepts require complete compositional and supplier information appropriate to the formula.

2026 fragrance-allergen labeling transition

Commission Regulation (EU) 2023/1545 expanded individual fragrance-allergen labeling requirements. The transition allowing affected non-compliant products to be placed on the Union market ran until 31 July 2026. As of August 2026, new placement must account for the applicable updated requirements. Products placed on the market under the transition may continue to be made available until 31 July 2028, subject to the Regulation’s conditions.

This can affect shampoos, conditioners, masks, oils, serums, styling products and hair perfumes. Brands should obtain updated allergen information from fragrance or essential-oil suppliers and revise the INCI artwork before ordering packaging.

Nanomaterials require specific attention

CPNP notification asks whether a product contains nanomaterials. Certain nanomaterials are also subject to an additional notification process under Article 16. Do not infer nano status from a marketing term or raw-material trade name; obtain appropriate supplier characterization and regulatory advice.

What Are the CPSR, Testing and PIF Requirements?

Cosmetic Product Safety Report

Before a cosmetic is placed on the market, the Responsible Person must ensure that it has undergone a safety assessment and that a CPSR is prepared in accordance with Annex I. The assessment must be performed by a person with the qualifications described in Article 10.

The CPSR is product-specific. Changing ingredient concentration, fragrance, preservative, color system, exposure, package or intended use may affect the assessment and must be reviewed. A CPSR from a similar formula cannot simply be renamed.

Testing is risk- and product-dependent

The exact program is established with the safety assessor and Responsible Person. It may include:

Physical and chemical specifications
Stability under defined conditions
Formula-packaging compatibility
Microbiological quality
Preservative efficacy or challenge testing where appropriate
Raw-material purity, impurity and toxicological information
Claim-substantiation studies
Additional assessments based on aerosol, dye, nano or other specific risks

An MSDS/SDS describes hazard and handling information. A COA reports defined test results for a material or batch. Neither document replaces a CPSR or the finished-product evidence required for the PIF.

Product Information File

The Responsible Person must keep a PIF readily accessible at the address shown on the label. Under Article 11, it includes:

A product description that clearly connects the file to the cosmetic
The CPSR
A description of the manufacturing method and a statement on GMP compliance
Proof of the effect claimed, where justified by the nature or effect of the product
Data on animal testing performed by the manufacturer, agents or suppliers in relation to development or safety assessment, as required by the Regulation

The PIF must be maintained for ten years after the date on which the last batch of the product was placed on the market. It should be updated when the formula, packaging, claims, manufacturing information or safety evidence changes.

What Does GMP Mean for an Imported Private Label Product?

Article 8 requires cosmetic manufacturing to comply with good manufacturing practice. Compliance is presumed where manufacturing follows relevant harmonized standards published in the Official Journal; EN ISO 22716 is commonly used for cosmetic GMP.

For the buyer, GMP is not just a certificate image. The project should connect the approved formula to controlled raw materials, manufacturing instructions, equipment, in-process checks, filling, coding, finished-product release, complaints, change control and traceability.

Ask whether the certificate or audit evidence applies to the actual production site and product scope. Confirm issuer, validity and covered activities. If an aerosol, electronic accessory or specialist process is subcontracted, define the role and controls of each facility.

What Must Appear on an EU Cosmetic Label?

Article 19 establishes mandatory label particulars. The exact presentation and language requirements should be checked for the Member States where the product will be sold. Depending on the product, the container and packaging must show information including:

Name or registered name and address of the Responsible Person
Country of origin for imported cosmetics
Nominal content at the time of packaging, subject to applicable exceptions
Date of minimum durability or period-after-opening information, as applicable
Particular precautions for use and relevant annex warnings
Batch number or reference for identification
Function of the cosmetic, unless clear from presentation
Ingredient list using the required common ingredient names and order rules

Do not finalize artwork before the safety and formula review

The assessor or Responsible Person may identify precautions, allergen declarations or claim changes that affect the label. Printing thousands of cartons before formula clearance creates avoidable waste.

Claims apply beyond the package

Commission Regulation (EU) No 655/2013 applies common criteria to cosmetic claims in text, names, trademarks, images and other signs, regardless of medium. Website copy, marketplace listings, social media and distributor materials should therefore match the evidence and cosmetic classification.

The six common criteria are legal compliance, truthfulness, evidential support, honesty, fairness and informed decision-making. A product should not claim characteristics it does not have, exceed the available evidence, denigrate legal ingredients or confuse consumers with a competitor.

Hair-growth and therapeutic claims need special control

Phrases such as “treats hair loss,” “reactivates dormant follicles,” “regrows hair” or “clinically cures alopecia” can create classification and substantiation problems. Cosmetic wording should reflect the product’s supported cosmetic function—for example, conditioning the scalp, reducing the appearance of breakage or making hair look fuller—only where the finished-product evidence supports it.

What Is CPNP—and What Is It Not?

The Cosmetic Products Notification Portal is the European Commission’s free online notification system for Regulation (EC) No 1223/2009. The Responsible Person submits required information before the cosmetic is placed on the EU market. Once notified through CPNP, no further national product notification is required within the EU under this cosmetics notification system.

CPNP is not:

An approval or authorization issued after a full product review
A substitute for a compliant formula, CPSR or PIF
A certificate proving that claims are lawful
A task the factory can always complete without an EU Responsible Person
A permanent clearance that remains valid after uncontrolled product changes

The notification includes information such as product category and name, Responsible Person details, country of origin for imports, Member State of first market placement, contact information, nanomaterial and CMR information where applicable, frame formulation information, and original labeling plus a photograph of corresponding packaging where reasonably legible.

See the European Commission’s official CPNP information page for the current portal guidance.

How Do Compliance Priorities Differ Across Hair Care Categories?

Category	Typical exposure	Project priorities
Shampoo	Rinse-off, scalp and hair	Surfactant system, preservation, eye exposure, allergens, claims
Conditioner and mask	Usually rinse-off; some leave-on products	Correct use category, stability, preservation, precautions, claim evidence
Hair oil and serum	Leave-on, hair or scalp	Exposure, oxidation, essential oils, allergens, therapeutic-claim boundary
Hair spray and aerosol	Leave-on with inhalation potential	Spray exposure, flammability/transport, package, warnings and ingredient restrictions
Styling powder and hair fibers	Leave-on dry particles	Particle exposure, ingredients, shade system, inhalation considerations, cosmetic claims
Hair dye	Hair/scalp contact with category-specific warnings	Annex III restrictions, permitted colorants, mandatory warnings, instructions and target age

Explore KINODIN’s hair cleansing and treatment, hair growth and scalp care, hair styling and hair color categories when defining the intended portfolio. Each SKU still requires its own market-specific compliance assessment.

What Should a Brand Request from Its OEM Hair Care Manufacturer?

Do not ask only, “Can you provide CPNP?” Send a compliance-focused brief and establish deliverables for the exact project.

Formula and raw-material package

Qualitative and quantitative formula under confidentiality controls
INCI names, functions and supplier identities as required by the assessor
Specifications, SDS, COA and supporting raw-material information
Fragrance composition/allergen statement and updates
Impurity, nano and other product-relevant information

Finished-product package

Product specification and test methods
Stability and packaging-compatibility evidence
Microbiological and preservative-efficacy information where applicable
Manufacturing method summary and GMP statement/evidence
Batch coding, traceability and sample-retention arrangements
Claim-support data agreed for the finished product

Commercial control package

Approved formula and packaging version
Change-control procedure
Ownership and access rights for CPSR, PIF inputs and test reports
Responsibility matrix for manufacturer, brand, importer, RP and assessor
Update obligations when EU ingredient rules change

KINODIN can coordinate formula selection, sampling, packaging and available manufacturing documentation through its OEM and private label services. Final EU market access remains a shared project involving the brand, importer, Responsible Person, safety assessor and other qualified advisers.

What Are the Most Common EU Private Label Compliance Mistakes?

Treating CPNP as government product approval
Assuming a GMP certificate makes every formula compliant
Using an SDS or COA instead of a CPSR
Copying another brand’s INCI list or warnings
Changing fragrance or package after the CPSR without review
Printing artwork before the Responsible Person reviews it
Using therapeutic hair-growth claims for a cosmetic serum
Ignoring Member State language requirements
Using outdated fragrance-allergen declarations after the 2026 transition
Failing to define who owns and maintains the PIF
Launching several variants but assessing only one formula
Assuming EU compliance automatically covers Great Britain or every EEA/non-EU market

Does Compliance End After CPNP Notification?

No. The Responsible Person and supply-chain partners need a post-market system. This can include:

Complaint and undesirable-effect intake
Serious undesirable effect reporting and cooperation with authorities
Batch traceability and distributor identification
Corrective action, withdrawal or recall where required
PIF and CPSR updates
Monitoring changes to the Cosmetics Regulation and other applicable rules
Controlled formula, supplier, package, claim and artwork changes

The manufacturer should notify the brand of relevant production or material changes. The brand and RP should determine whether reassessment, updated artwork, revised CPNP data or other action is required before the changed product is supplied.

Frequently Asked Questions About EU Hair Care Compliance

Does a Chinese private label hair care manufacturer need to be the EU Responsible Person?

No. The Responsible Person must be established within the EU. The importer may be the RP, or another EU-established person may be designated and accept the role in writing, depending on the arrangement and Regulation.

Is CPNP a product approval certificate?

No. CPNP is a notification system. Notification does not mean that the European Commission has approved the formula, claims, CPSR or label.

Can one CPSR cover several fragrances or shades?

Possibly, if a qualified safety assessor determines that the variants can be assessed within an appropriate documented framework. A brand should never assume coverage; every composition difference must be disclosed and evaluated.

Is an MSDS enough to sell shampoo in the EU?

No. An SDS does not replace formula compliance, Responsible Person appointment, CPSR, PIF, GMP, compliant labeling, claims evidence or CPNP notification.

Who owns the PIF for a private label product?

Ownership and access should be contractually clear, but the Responsible Person must keep the required PIF readily accessible to authorities. The manufacturer must provide agreed confidential information needed to compile and maintain it.

Can a cosmetic hair serum claim to regrow hair?

Such a claim may create classification and evidence problems and should not be used merely because the formula contains fashionable ingredients. Claims must remain within the cosmetic function and be supported by adequate evidence.

Do the expanded fragrance-allergen rules matter in August 2026?

Yes. The transition date for placing affected non-compliant products on the EU market was 31 July 2026. Products placed under the transition may continue to be made available until 31 July 2028, subject to the Regulation’s conditions.

Does EU compliance include the United Kingdom?

Not automatically. Great Britain has its own cosmetics framework and notification route. Northern Ireland can involve different arrangements. Obtain market-specific advice rather than using “EU/UK compliant” as one undifferentiated claim.

Build Compliance into the Product Brief—Not onto the Finished Carton

The safest and most efficient private label project aligns the formula, Responsible Person, assessor, evidence, packaging and claims before mass production. A manufacturer can support documents and technical coordination, but no single certificate replaces the full legal system. Start with one clearly classified SKU, freeze the commercial formula, complete the safety and information file, approve the correct label, notify through CPNP and control every subsequent change.

Send your EU private label hair care brief to KINODIN →